These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2843242)
1. Evidence that ecto-nucleoside-triphosphate pyrophosphatase serves in the generation of extracellular inorganic pyrophosphate in human bone and articular cartilage. Caswell AM; Russell RG Biochim Biophys Acta; 1988 Sep; 966(3):310-7. PubMed ID: 2843242 [TBL] [Abstract][Full Text] [Related]
2. Identification of ecto-nucleoside triphosphate pyrophosphatase in human articular chondrocytes in monolayer culture. Caswell AM; Russell RG Biochim Biophys Acta; 1985 Oct; 847(1):40-7. PubMed ID: 2996615 [TBL] [Abstract][Full Text] [Related]
3. Nucleoside triphosphate pyrophosphatase of rabbit matrix vesicles, a mechanism for the generation of inorganic pyrophosphate in epiphyseal cartilage. Caswell AM; Ali SY; Russell RG Biochim Biophys Acta; 1987 May; 924(2):276-83. PubMed ID: 3032274 [TBL] [Abstract][Full Text] [Related]
4. Cartilage nucleoside triphosphate pyrophosphohydrolase. II. Role in extracellular pyrophosphate generation and nucleotide metabolism. Ryan LM; Wortmann RL; Karas B; McCarty DJ Arthritis Rheum; 1985 Apr; 28(4):413-8. PubMed ID: 2985090 [TBL] [Abstract][Full Text] [Related]
5. Cartilage nucleoside triphosphate (NTP) pyrophosphohydrolase. I. Identification as an ecto-enzyme. Ryan LM; Wortmann RL; Karas B; McCarty DJ Arthritis Rheum; 1984 Apr; 27(4):404-9. PubMed ID: 6143564 [TBL] [Abstract][Full Text] [Related]
6. One of two chondrocyte-expressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist. Johnson K; Farley D; Hu SI; Terkeltaub R Arthritis Rheum; 2003 May; 48(5):1302-14. PubMed ID: 12746903 [TBL] [Abstract][Full Text] [Related]
7. The nucleoside triphosphate pyrophosphohydrolase isozyme PC-1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles. Johnson K; Pritzker K; Goding J; Terkeltaub R J Rheumatol; 2001 Dec; 28(12):2681-91. PubMed ID: 11764218 [TBL] [Abstract][Full Text] [Related]
8. Augmentation of inorganic pyrophosphate elaboration in cartilage by serum factors. Rosenthal AK; Cheung HS; Ryan LM Arch Biochem Biophys; 1989 Aug; 272(2):386-92. PubMed ID: 2546498 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug. Danino O; Svetitsky S; Kenigsberg S; Levin A; Journo S; Gold A; Drexler M; Snir N; Elkayam O; Fischer B; Arad U Rheumatology (Oxford); 2018 Aug; 57(8):1472-1480. PubMed ID: 29688536 [TBL] [Abstract][Full Text] [Related]
10. Inorganic pyrophosphate (PPI) in pathologic calcification of articular cartilage. Johnson K; Terkeltaub R Front Biosci; 2005 Jan; 10():988-97. PubMed ID: 15569637 [TBL] [Abstract][Full Text] [Related]
11. Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Johnson K; Hashimoto S; Lotz M; Pritzker K; Goding J; Terkeltaub R Arthritis Rheum; 2001 May; 44(5):1071-81. PubMed ID: 11352238 [TBL] [Abstract][Full Text] [Related]
12. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. Hirose J; Ryan LM; Masuda I Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta increases ecto-nucleoside triphosphate pyrophosphatase activity of human bone-derived cells. Oyajobi BO; Caswell AM; Russell RG J Bone Miner Res; 1994 Jan; 9(1):99-109. PubMed ID: 8154315 [TBL] [Abstract][Full Text] [Related]
15. Comparison of phosphohydrolase activities from articular cartilage in calcium pyrophosphate deposition disease and primary osteoarthritis. Tenenbaum J; Muniz O; Schumacher HR; Good AE; Howell DS Arthritis Rheum; 1981 Mar; 24(3):492-500. PubMed ID: 6111322 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of inorganic pyrophosphate elaboration by cultured cartilage and chondrocytes. Ryan LM; Kurup I; Rosenthal AK; McCarty DJ Arch Biochem Biophys; 1989 Aug; 272(2):393-9. PubMed ID: 2546499 [TBL] [Abstract][Full Text] [Related]
17. Ecto-nucleoside triphosphate pyrophosphohydrolase activity and calcium pyrophosphate dihydrate crystal deposition disease. Wortmann RL; Ryan LM; Karas B; McCarthy DJ Adv Exp Med Biol; 1986; 195 Pt A():153-6. PubMed ID: 3014830 [TBL] [Abstract][Full Text] [Related]
18. Inorganic pyrophosphate, nucleoside triphosphate pyrophosphatase, and cartilage fragments in normal human synovial fluid. Hamilton E; Pattrick M; Doherty M Br J Rheumatol; 1991 Aug; 30(4):260-4. PubMed ID: 1650620 [TBL] [Abstract][Full Text] [Related]
19. Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes. Johnson K; Vaingankar S; Chen Y; Moffa A; Goldring MB; Sano K; Jin-Hua P; Sali A; Goding J; Terkeltaub R Arthritis Rheum; 1999 Sep; 42(9):1986-97. PubMed ID: 10513816 [TBL] [Abstract][Full Text] [Related]
20. Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate. Ryan LM; Rachow JW; McCarty DJ J Rheumatol; 1991 May; 18(5):716-20. PubMed ID: 1650841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]